Copyright
©The Author(s) 2021.
World J Gastroenterol. Apr 7, 2021; 27(13): 1330-1340
Published online Apr 7, 2021. doi: 10.3748/wjg.v27.i13.1330
Published online Apr 7, 2021. doi: 10.3748/wjg.v27.i13.1330
Variables | Short-term survival | Long-term survival | ||
OR (95%CI) | P value | OR (95%CI) | P value | |
Total bilirubin, µmol/L | 1.027 (1-1.054) | 0.046 | ||
AST, U/L | 1.014 (1.006-1.021) | P < 0.01 | ||
Sex | ||||
Men | 1 | |||
Women | 2.832 (1.025-7.828) | 0.045 | ||
Type of gross pathology | ||||
Massive | 1 | |||
Nodular and diffuse | 0.197 (0.075-0.521) | 0.001 | ||
Number of tumors | ||||
1 | 1 | |||
2 | 1.365 (0.283-6.581) | 0.698 | ||
3 | 5.809 (1.563-21.594) | 0.009 |
- Citation: Chen KL, Gao J. Factors influencing the short-term and long-term survival of hepatocellular carcinoma patients with portal vein tumor thrombosis who underwent chemoembolization. World J Gastroenterol 2021; 27(13): 1330-1340
- URL: https://www.wjgnet.com/1007-9327/full/v27/i13/1330.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i13.1330